303 related articles for article (PubMed ID: 11791665)
1. Mycobacterium leprae and leprosy: a compendium.
Sasaki S; Takeshita F; Okuda K; Ishii N
Microbiol Immunol; 2001; 45(11):729-36. PubMed ID: 11791665
[TBL] [Abstract][Full Text] [Related]
2. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals.
Rojas-Espinosa O; Løvik M
Rev Sci Tech; 2001 Apr; 20(1):219-51. PubMed ID: 11288514
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
5. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium leprae's evolution and environmental adaptation.
Chavarro-Portillo B; Soto CY; Guerrero MI
Acta Trop; 2019 Sep; 197():105041. PubMed ID: 31152726
[TBL] [Abstract][Full Text] [Related]
7. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.
Yamauchi PS; Bleharski JR; Uyemura K; Kim J; Sieling PA; Miller A; Brightbill H; Schlienger K; Rea TH; Modlin RL
J Immunol; 2000 Aug; 165(3):1506-12. PubMed ID: 10903757
[TBL] [Abstract][Full Text] [Related]
8. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of leprosy.
Ishii N
Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458
[TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of immunopathology induced by Mycobacterium leprae.
de Vries RR
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):12-6. PubMed ID: 1904200
[TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
14. Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis.
Silva FJ; Santos-Garcia D; Zheng X; Zhang L; Han XY
Microbiol Spectr; 2022 Jun; 10(3):e0169221. PubMed ID: 35467405
[TBL] [Abstract][Full Text] [Related]
15. Differential growth of Mycobacterium leprae strains (SNP genotypes) in armadillos.
Sharma R; Singh P; Pena M; Subramanian R; Chouljenko V; Kim J; Kim N; Caskey J; Baudena MA; Adams LB; Truman RW
Infect Genet Evol; 2018 Aug; 62():20-26. PubMed ID: 29665434
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy.
Teles RM; Krutzik SR; Ochoa MT; Oliveira RB; Sarno EN; Modlin RL
Infect Immun; 2010 Nov; 78(11):4634-43. PubMed ID: 20713631
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel open reading frames in the intergenic regions of Mycobacterium leprae genome and detection of transcript by qRT-PCR.
Sharma M; Das M; Diana D; Wedderburn A; Anindya R
Microb Pathog; 2018 Nov; 124():316-321. PubMed ID: 30172902
[TBL] [Abstract][Full Text] [Related]
20. High antibody levels to the mycobacterial fibronectin-binding antigen of 30-31 kD in tuberculosis and lepromatous leprosy.
Espitia C; Sciutto E; Bottasso O; González-Amaro R; Hernández-Pando R; Mancilla R
Clin Exp Immunol; 1992 Mar; 87(3):362-7. PubMed ID: 1371953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
